Welcome to our dedicated page for Quanterix news (Ticker: QTRX), a resource for investors and traders seeking the latest updates and insights on Quanterix stock.
Quanterix Corporation develops and commercializes ultra-sensitive biomarker tools for life sciences research and clinical testing. Its business includes Simoa instruments, assay kits, consumables, spatial biology systems, contract research services, and clinical laboratory testing through its Accelerator Laboratory and Lucent Diagnostics brand.
QTRX news commonly covers biomarker testing for cognitive disease, including blood-based Alzheimer’s disease panels, collaborations that connect Lucent Diagnostics tests with clinical and community workflows, and updates tied to operating results. Company developments also include shareholder voting matters, governance changes, capital-structure disclosures, and clinical or regulatory topics related to its diagnostic and research offerings.
Quanterix Corporation (NASDAQ: QTRX) announced a Phase 2 contract with the National Institutes of Health, valued at $18.2 million, to advance a novel SARS-CoV-2 antigen test utilizing their Simoa technology. This funding supports clinical validation and aims for emergency use authorization submissions with the FDA. The contract also facilitates expanded manufacturing capacities at Quanterix's Billerica, Massachusetts facility. Initial feasibility of the test was previously supported by a Phase 1 award. The contract period extends through September 2021.
Quanterix Corporation (NASDAQ: QTRX) has entered a non-exclusive royalty-bearing license agreement with Abbott Laboratories (NYSE: ABT), granting Abbott access to Quanterix's bead-based technology patents for in vitro diagnostic (IVD) applications. This agreement includes an initial license fee, milestone fees contingent on Abbott's future development achievements, and royalties on sales of licensed products. Quanterix aims to advance precision health through its digital health solution, Simoa, improving disease detection and treatment methods.